Shares of Bruker Corporation (BRKR), a leading provider of scientific instruments and analytical solutions, plummeted by as much as 7.80% in early trading on Monday, following the release of the company's third-quarter 2024 financial results and lowered guidance for the full year.

For the third quarter, Bruker reported non-GAAP earnings per share of $0.60, narrowly beating analysts' expectations of $0.59. However, revenue of $864.4 million, while surpassing the consensus estimate of $859.4 million, fell short of investors' expectations. The company's adjusted earnings per share declined from $0.74 in the year-ago period, indicating potential challenges in its core markets.

Compounding the disappointment, Bruker lowered its full-year 2024 guidance, now expecting revenue in the range of $3.34 billion to $3.37 billion, down from its previous forecast of $3.38 billion to $3.44 billion. The company also revised its non-GAAP earnings per share guidance for 2024 to a range of $2.36 to $2.41, below the previous guidance of $2.59 to $2.64. These revisions fell short of analysts' consensus estimates, raising concerns about the company's growth prospects and profitability.